Insider Selling: Inotiv, Inc. (NASDAQ:NOTV) CFO Sells 4,370 Shares of Stock

Inotiv, Inc. (NASDAQ:NOTV) CFO Beth Taylor sold 4,370 shares of the company’s stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $4.01, for a total transaction of $17,523.70. Following the completion of the sale, the chief financial officer now directly owns 108,368 shares of the company’s stock, valued at $434,555.68. The trade was a 3.88 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.

Beth Taylor also recently made the following trade(s):

• On Friday, January 31st, Beth Taylor sold 2,054 shares of Inotiv stock. The shares were sold at an average price of $4.46, for a total transaction of $9,160.84.

Inotiv Trading Down 4.5 %

NASDAQ:NOTV opened at $4.06 on Friday. Inotiv, Inc. has a 52 week low of $1.23 and a 52 week high of $11.42. The firm has a 50 day moving average of $4.33 and a 200 day moving average of $2.96. The company has a quick ratio of 1.28, a current ratio of 1.57 and a debt-to-equity ratio of 2.31. The stock has a market capitalization of $136.90 million, a price-to-earnings ratio of -0.88 and a beta of 3.58.

Inotiv (NASDAQ:NOTV) last posted its earnings results on Wednesday, February 5th. The company reported ($0.42) EPS for the quarter, missing analysts’ consensus estimates of ($0.32) by ($0.10). Inotiv had a negative net margin of 25.40% and a negative return on equity of 15.41%. As a group, sell-side analysts anticipate that Inotiv, Inc. will post -0.79 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the stock. Bay Colony Advisory Group Inc d b a Bay Colony Advisors acquired a new position in Inotiv during the 4th quarter valued at approximately $60,000. Virtu Financial LLC acquired a new position in Inotiv during the 4th quarter valued at approximately $76,000. Two Sigma Advisers LP increased its stake in Inotiv by 31.6% during the 4th quarter. Two Sigma Advisers LP now owns 22,500 shares of the company’s stock valued at $93,000 after purchasing an additional 5,400 shares in the last quarter. Dimensional Fund Advisors LP increased its stake in Inotiv by 24.5% during the 4th quarter. Dimensional Fund Advisors LP now owns 31,626 shares of the company’s stock valued at $131,000 after purchasing an additional 6,216 shares in the last quarter. Finally, LPL Financial LLC acquired a new position in Inotiv during the 4th quarter valued at approximately $136,000. Institutional investors and hedge funds own 18.17% of the company’s stock.

About Inotiv

Inotiv, Inc provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries. It operates through two segment: Discovery and Safety Assessment (DSA), and Research Models and Services (RMS). The DMS segment manufactured scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the Company's BASi product line.